Present-day clinical trials under-represent ethnic minorities and women. Etcembly is building a pioneering framework to address future pandemic response and personalised treatment options. There is a powerful synergy between the successes of Machine Learning and Immunology. We’ve founded Etcembly Ltd to exploit this to the full. The team digitises the bench data of T cell repertoires on our proprietary platform EMLyTM (Etcembly Machine Learning) to map the entire sequence space. We’re actively looking for polymaths. Individuals who are comfortable with both computation and biology, who while playing at the top of their game can also communicate their insights clearly to healthcare professionals. To be part of our team – please email hello@etcembly.com